Beta-Amyloid (1-42), NH4OH

Ambient

Beta-amyloid peptide (Abeta), the major constituent of amyloid plaques in the brains of Alzheimer's patients, is thought to be the cause of Alzheimer's Disease (AD). AD is the most common neurodegenerative disease and afflicts about 10% of the population over 60. Using a proprietary production technique that limits the peptide's conformational changes, rPeptide has produced an ammonium hydroxide beta amyloid counter-ion. The Abeta ammonium hydroxide product can be utilized for in vitro aggregation experiments as well as cell based assays.